Menu

Solid Biosciences Inc. SLDB

Full chart Compare
Set alert

Price alert · SLDB

All alert types
6.59 USD +0.41 (+6.63%)

At closeNov 6, 2026, 6:03 PM EST

6.72 +0.13 +1.97%

After hours · Nov 6, 6:03 PM ET

6.18 Day range 6.73
4.06 52-week range 11.15
YTD
+16.84%
1 year
+56.16%

Revenue & Expenses

Other Income → Expenses: $20.47MExpenses → Selling, General & Admin: $28.95MExpenses → Research & Development: $78.42MExpenses → Other Operating Expenses: $7.18MGross Profit → Expenses: $8.09MRevenue → Gross Profit: $8.09MNet Loss → Expenses: $85.98MOther Income$20.47MGross Profit$8.09MNet Loss$85.98MExpenses$114.55MSelling, General & Admin$28.95MResearch & Development$78.42MOther Operating Expenses$7.18MRevenue$8.09M

Latest period ending Dec 31, 2025 · select a line to chart its full history

SLDB annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-179.21M-129.73M-104.25M-106.45M-72.25M
-174.32M-124.70M-96.02M-85.98M-72.19M
-1.99-3.06-4.83-10.10-10.14
SLDB annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
61.12M80.23M74.02M157.22M121.21M
232.54M188.66M164.94M260.25M232.38M
52.53M51.42M38.46M48.59M24.17M
21.16M24.18M26.27M28.55M2.06M
180.01M137.25M126.48M211.67M208.21M
SLDB annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-156.29M-100.01M-94.18M-97.98M-77.76M
-58.45M-16.09M9.69M59.16M-91.09M
194.45M122.44M3.12M74.83M134.99M
-1.07M-649.00K-1.51M-2.42M-1.28M
-20.30M6.34M-81.37M36.01M-33.87M